Back to US BANCORP \DE\ US BANCORP \DE\

SNOASNOA
8 quarters

Position history for US BANCORP \DE\US BANCORP \DE\'s holdings in SONOMA PHARMACEUTICALS INC

No. US Bancorp exited its SNOA (Sonoma Pharmaceuticals) position in Q2 2026. Its Q1 2026 13F listed 25 shares worth $53. US Bancorp first reported SNOA in Q3 2024 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$77

Total Shares Change

-25

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$1.23
0
2026-Q1
Unchanged
25
0.0%
$530.0%$2.75
0
2025-Q4
Unchanged
25
0.0%
$910.0%$3.62
0
2025-Q3
Unchanged
25
0.0%
$970.0%$3.94
0
2025-Q2
Unchanged
25
0.0%
$710.0%$2.87
0
2025-Q1
Unchanged
25
0.0%
$550.0%$2.41
0
2024-Q4
Unchanged
25
0.0%
$670.0%$2.75
0
2024-Q3
New
25
-
$770.0%$3.21
17

Other major holders of SNOA: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used